Protalix BioTherapeutics, Inc. (PLX)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $314
- Nov 18 · Unusual
- Form 4 sales
- 54
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 salePlan not statedMar 11 2013
Sold 35,198 shares at $5.79 ($204k)
Akirov Alfred, Director
Sold 0.7% of holdings ($29.4M position)5M shares leftFiling
- 2 Form 4 salePlan not statedMar 12 +1 day
Sold 10,000 shares at $5.70 ($57k)
Akirov Alfred, Director
Sold 0.2% of holdings ($28.7M position)5M shares leftFiling
- 3 Form 4 saleUnusualAug 15 +156 days
Sold 112,330 shares at $5.05 ($568k)
Akirov Alfred, Director
Sold 2.2% of holdings ($25.4M position)4.9M shares left8.6x usual sizeFiling
- 4 Form 4 saleUnusualAug 13 +363 days
Sold 4.4M shares at $2.47 ($10.9M)
Bio-Cell Ltd, 10% owner
Sold 30.4% of holdings ($35.7M position)10.1M shares leftFirst sale on recordFiling
- 5 Form 4 saleUnusualAug 13 same day
Sold 4.4M shares at $2.47 ($10.9M)
Bronfeld Zeev, Director, 10% owner
Sold 30.4% of holdings ($35.7M position)10.1M shares leftFirst sale on recordFiling
- 6 Form 4 salePlan not statedDec 2 +842 days
Sold 2.5M shares at $0.32 ($800k)
Camber Capital Management LLC, 10% owner
Sold 18.8% of holdings ($4.2M position)10.8M shares leftFirst sale on recordFiling
- 7 Form 4 salePlan not statedJun 3 +1644 days
Sold 918,717 shares at $2.27 ($2.1M)
Oren Dan, 10% owner
Sold 20.2% of holdings ($10.3M position)3.6M shares leftFirst sale on recordFiling
- 8 Form 4 saleUnusualNov 18 +1629 days
Sold 168 shares at $1.87 ($314)
Bar-Shalev Amos, Director
No 10b5-1 planSold 100% of holdings ($314 position)0 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (54)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | Bar-Shalev Amos | Director | Form 4 sale | 168 | $314 | 100.0% | Unusual | SEC |
| Jun 3, 2021 | Oren Dan | 10% owner | Form 4 sale | 918,717 | $2.1M | 20.2% | Plan not stated | SEC |
| Dec 2, 2016 | Camber Capital Management LLC | 10% owner | Form 4 sale | 2.5M | $800k | 18.8% | Plan not stated | SEC |
| Aug 13, 2014 | Bronfeld Zeev | Director, 10% owner | Form 4 sale | 4.4M | $10.9M | 30.4% | Unusual | SEC |
| Aug 13, 2014 | Bio-Cell Ltd | 10% owner | Form 4 sale | 4.4M | $10.9M | 30.4% | Unusual | SEC |
| Aug 15, 2013 | Akirov Alfred | Director | Form 4 sale | 112,330 | $568k | 2.2% | Unusual | SEC |
| Mar 12, 2013 | Akirov Alfred | Director | Form 4 sale | 10,000 | $57k | 0.2% | Plan not stated | SEC |
| Mar 11, 2013 | Akirov Alfred | Director | Form 4 sale | 35,198 | $204k | 0.7% | Plan not stated | SEC |
| Mar 7, 2013 | Akirov Alfred | Director | Form 4 sale | 13,135 | $75k | 0.3% | Plan not stated | SEC |
| May 2, 2012 | Shaaltiel Yoseph | Executive VP, R&D | Form 4 sale | 300,000 | $2.1M | 39.3% | Unusual | SEC |
| May 2, 2012 | Maimon Yossi | VP, Chief Financial Officer | Form 4 sale | 125,964 | $898k | 100.0% | Unusual | SEC |
| May 2, 2012 | Aviezer David | President & CEO | Form 4 sale | 450,000 | $3.2M | 100.0% | Unusual | SEC |
| May 2, 2012 | Almon Einat Brill | SVP, Product Development | Form 4 sale | 166,848 | $1.2M | 100.0% | Unusual | SEC |
| Oct 7, 2010 | Maimon Yossi | VP, Chief Financial Officer | Form 4 sale | 70,000 | $677k | 100.0% | Unusual | SEC |
| Oct 6, 2010 | Almon Einat Brill | VP, Product Development | Form 4 sale | 70,000 | $637k | 100.0% | Unusual | SEC |
| Sep 7, 2010 | Maimon Yossi | VP, Chief Financial Officer | Form 4 sale | 70,000 | $565k | 100.0% | Unusual | SEC |
| Sep 7, 2010 | Almon Einat Brill | VP, Product Development | Form 4 sale | 50,000 | $404k | 100.0% | Unusual | SEC |
| Aug 6, 2010 | Shaaltiel Yoseph | Executive VP, R&D | Form 4 sale | 53,027 | $371k | 6.5% | Plan not stated | SEC |
| Jun 21, 2010 | Shaaltiel Yoseph | Executive VP, R&D | Form 4 sale | 52,973 | $371k | 6.1% | Plan not stated | SEC |
| Apr 29, 2010 | Shaaltiel Yoseph | Executive VP, R&D | Form 4 sale | 12,691 | $89k | 1.4% | Plan not stated | SEC |
| Apr 14, 2010 | Shaaltiel Yoseph | Executive VP, R&D | Form 4 sale | 1,309 | $9k | 0.1% | Plan not stated | SEC |
| Mar 25, 2010 | Shaaltiel Yoseph | Executive VP, R&D | Form 4 sale | 380,000 | $2.7M | 30.1% | Unusual | SEC |
| Nov 12, 2009 | Hurvitz Eli | Director | Form 4 sale | 1.4M | $13.9M | 47.5% | Unusual | SEC |
| Oct 21, 2009 | Aviezer David | CEO and President | Form 4 sale | 244,238 | $2.3M | 100.0% | Unusual | SEC |
| Oct 19, 2009 | Almon Einat Brill | VP, Product Development | Form 4 sale | 90,000 | $847k | 100.0% | Unusual | SEC |
| Oct 19, 2009 | Shaaltiel Yoseph | Executive VP, R&D | Form 4 sale | 100,000 | $941k | 7.3% | Unusual | SEC |
| Oct 16, 2009 | Maimon Yossi | VP, Chief Financial Officer | Form 4 sale | 150,000 | $1.4M | 100.0% | Unusual | SEC |
| Sep 10, 2009 | Frost Phillip Md Et Al | 10% owner | Form 4 sale | 178,074 | $1.3M | 2.3% | Plan not stated | SEC |
| Sep 3, 2009 | Frost Phillip Md Et Al | 10% owner | Form 4 sale | 75,000 | $517k | 1.0% | Plan not stated | SEC |
| Aug 28, 2009 | Frost Gamma Investments Trust | 10% owner | Form 4 sale | 67,307 | $404k | 0.8% | Plan not stated | SEC |
| Aug 26, 2009 | Frost Phillip Md Et Al | 10% owner | Form 4 sale | 54,500 | $333k | 0.7% | Plan not stated | SEC |
| Aug 25, 2009 | Frost Gamma Investments Trust | 10% owner | Form 4 sale | 531,865 | $3.2M | 6.2% | Unusual | SEC |
| Aug 21, 2009 | Frost Gamma Investments Trust | 10% owner | Form 4 sale | 115,000 | $701k | 1.3% | Plan not stated | SEC |
| Aug 19, 2009 | Frost Phillip Md Et Al | 10% owner | Form 4 sale | 176,989 | $1.1M | 2.0% | Plan not stated | SEC |
| Aug 17, 2009 | Frost Gamma Investments Trust | 10% owner | Form 4 sale | 231,952 | $1.5M | 2.6% | Plan not stated | SEC |
| Aug 13, 2009 | Frost Gamma Investments Trust | 10% owner | Form 4 sale | 150,000 | $900k | 1.6% | Plan not stated | SEC |
| Aug 12, 2009 | Frost Gamma Investments Trust | 10% owner | Form 4 sale | 150,000 | $924k | 1.6% | Plan not stated | SEC |
| Aug 11, 2009 | Frost Phillip Md Et Al | 10% owner | Form 4 sale | 44,252 | $272k | 0.5% | Plan not stated | SEC |
| Aug 10, 2009 | Frost Gamma Investments Trust | 10% owner | Form 4 sale | 117,443 | $725k | 1.2% | Plan not stated | SEC |
| Aug 6, 2009 | Frost Phillip Md Et Al | 10% owner | Form 4 sale | 112,224 | $788k | 1.2% | Plan not stated | SEC |
| Aug 3, 2009 | Frost Gamma Investments Trust | 10% owner | Form 4 sale | 146,500 | $1M | 1.5% | Plan not stated | SEC |
| Jul 24, 2009 | Frost Gamma Investments Trust | 10% owner | Form 4 sale | 20,000 | $125k | 0.2% | Plan not stated | SEC |
| Jul 7, 2009 | Almon Einat Brill | VP, Product Development | Form 4 sale | 55,000 | $280k | 100.0% | Unusual | SEC |
| Jul 7, 2009 | Maimon Yossi | VP, Chief Financial Officer | Form 4 sale | 50,000 | $255k | 100.0% | Unusual | SEC |
| Jul 6, 2009 | Shaaltiel Yoseph | Executive VP, R&D | Form 4 sale | 100,000 | $509k | 6.8% | Plan not stated | SEC |
| May 18, 2009 | Almon Einat Brill | VP, Product Development | Form 4 sale | 40,000 | $160k | 100.0% | Unusual | SEC |
| May 18, 2009 | Maimon Yossi | VP, Chief Financial Officer | Form 4 sale | 30,000 | $120k | 100.0% | Unusual | SEC |
| May 14, 2009 | Shaaltiel Yoseph | Executive VP, R&D | Form 4 sale | 30,000 | $109k | 2.0% | Plan not stated | SEC |
| May 12, 2009 | Aviezer David | President & CEO | Form 4 sale | 100,000 | $341k | 100.0% | Unusual | SEC |
| May 6, 2009 | Aviezer David | President & CEO | Form 4 sale | 75,000 | $227k | 100.0% | Unusual | SEC |
| Apr 20, 2009 | Aviezer David | President & CEO | Form 4 sale | 50,000 | $126k | 100.0% | Unusual | SEC |
| Mar 13, 2009 | Maimon Yossi | VP, Chief Financial Officer | Form 4 sale | 48,590 | $109k | 100.0% | Unusual | SEC |
| Mar 13, 2009 | Shaaltiel Yoseph | Executive VP, R&D | Form 4 sale | 8,300 | $18k | 0.6% | Plan not stated | SEC |
| Feb 25, 2008 | Yossi Maimon | VP, Chief Financial Officer | Form 4 sale | 33,300 | $106k | 55.5% | Unusual | SEC |